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Abstract
Background: Several computational methods have been developed to predict protein-protein interactions from
amino acid sequences, but most of those methods are intended for the interactions within a species rather than
for interactions across different species. Methods for predicting interactions between homogeneous proteins are
not appropriate for finding those between heterogeneous proteins since they do not distinguish the interactions
between proteins of the same species from those of different species.
Results: We developed a new method for representing a protein sequence of variable length in a frequency
vector of fixed length, which encodes the relative frequency of three consecutive amino acids of a sequence. We
built a support vector machine (SVM) model to predict human proteins that interact with virus proteins. In two
types of viruses, human papillomaviruses (HPV) and hepatitis C virus (HCV), our SVM model achieved an average
accuracy above 80%, which is higher than that of another SVM model with a different representation scheme.
Using the SVM model and Gene Ontology (GO) annotations of proteins, we predicted new interactions between
virus proteins and human proteins.
Conclusions: Encoding the relative frequency of amino acid triplets of a protein sequence is a simple yet powerful
representation method for predicting protein-protein interactions across different species. The representation
method has several advantages: (1) it enables a prediction model to achieve a better performance than other
representations, (2) it generates feature vectors of fixed length regardless of the sequence length, and (3) the same
representation is applicable to different types of proteins.
Background
A variety of viruses cause diseases in humans, and viral
infections affect millions of people each year. The treat-
ment and prevention of viral infections and their associated
diseases are the main public health challenges. Common
examples of viruses associated with human diseases include
HIV-1, influenza virus, human papillomavirus (HPV),
herpes virus, and hepatitis A, B, C, D and E viruses. Differ-
ent viral species have different infection mechanisms, and
identifying host cell proteins that are attacked by a virus
will certainly help better understand the infection mechan-
ism and to design new antiviral strategies. Recently, pro-
teome-wide studies of viral interactions with human
proteins were performed, but comprehensive analysis
of the interactions between virus proteins and human pro-
teins involved in viral infection has not yet been
investigated.
So far, most computational studies of protein-protein
interactions (PPIs) have focused on the interactions
between proteins of the same species. For example, Bock
and Gough [1] created protein structural and physiochem-
ical descriptors based on the sequence data, and trained a
support vector machine classifier to identify PPIs from the
descriptors. There are many other studies that used a sup-
port vector machine to predict PPIs in several organisms
[2-6].Wu et al. [7] used the Gene Ontology (GO) and
other annotations to predict PPIs in yeast. Nanni [8] pre-
dicted PPIs in the human gastric bacterium Helicobacter
pylori by combining a linear discriminant classifier and
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method to assess and predict PPIs. All these methods are
intended for the protein-protein interactions within a spe-
cies rather than for those across different species. Methods
typically used to predict interactions between homoge-
neous proteins are not appropriate for predicting those
between heterogeneous proteins, since such methods do
not distinguish interactions between proteins of the same
species from those of different species.
In this paper, we propose a representation method and a
support vector machine (SVM) model to predict the inter-
actions between two types of viruses (hepatitis C virus and
human papillomaviruses) and human proteins. Although
substantial progress has been made in clinical and basic
research on the hepatitis C virus (HCV) and human papil-
lomaviruses (HPV), interactions between these viruses and
human proteins are not yet fully understood. Identifying
more interactions between them should help elucidate the
interaction mechanism of HCV and HPV with host cells,
and can be helpful in designing molecules that target the
new interacting proteins.
Methods
Representation of protein sequences
One of the challenges in predicting protein-protein inter-
actions from sequences is to find a way of fully encoding
the important information content of protein sequences.
In addition, the amino acid sequences of different lengths
should be transformed into a feature vector of the same
length. We represent a protein sequence using three con-
secutive amino acids called amino acid triplet. For exam-
ple, in the amino acid sequence TVAVTVA, there are
four overlapping amino acid triplets, TVA, VAV, AVT
and VTV. To reduce the dimension of the vector space
of feature vectors, we represent an amino acid sequence
using the class of amino acids. Based on the biochemical
similarity of amino acids, twenty amino acids were classi-
fied into six categories: {IVLM}, {FYW}, {HKR}, {DE},
{QNTP}, and {ACGS} [10,11]. Using this classification of
amino acids, there are 6×6×6 = 216 possible amino acid
triplets.
W eu s eab i n a r ys p a c e( V ,F )t or e p r e s e n tap r o t e i n
sequence, in which V is a vector space of feature vectors
with a fixed number of features and F is a vector space of
frequency vectors. A protein sequence of variable length is
first mapped to a feature vector of fixed length. A feature
vector v is then mapped to a relative frequency vector di
(i=1, 2, ..., 216), which is defined by equation 1.
di =
⎧
⎪ ⎨
⎪ ⎩
e
ﬁ − min{f1,f2,...,f216}
max{f1,f2,...,f216}−min{f1,f2,...,f216}
⎫
⎪ ⎬
⎪ ⎭
− 1 (1)
where fi is the frequency of the i-th triplet type in the
sequence. The value of di ranges from 0 to 1.714.
There are two differences between our representation
and that of Shen et al. [5], namely in the classification
of amino acids and in the definition of the relative fre-
quency of an amino acid triplet. First, Shen et al.[ 5 ]
clustered the 20 amino acids into seven classes, {AVG},
{ILFP}, {YMTS}, {HNQW}, {RK}, {DE}, {C}, based on the
diploes and volumes of the side chains of amino acids,
and there are 7×7×7 = 343 possible amino acid triplets.
Second, the relative frequency of a triplet in their repre-
sentation is defined by equation 2.
di =
fi − min{f1,f2,...,f343}
max{f1,f2,...,f343}−min{f1,f2,...,f343}
(2)
While the relative frequency in the representation of
Shen et al. [5] has a value in the range 0[1], it ranges
from 0 to 1.714 in our representation. Thus, the relative
frequency value in a wider range makes it easier to dis-
criminate protein sequences as we will show later in the
results section.
In addition to the relative frequencies of amino acid
triplets, a feature element representing the types of virus
proteins (11 types of HCV proteins and 9 types of HPV
proteins) were included in a feature vector. Each feature
vector was labelled +1 for interaction and -1 for non-
interaction. By encoding the type of a virus protein, the
SVM model can find a human protein interacting with
the virus protein.
Support vector machine
A support vector machine (SVM) has been applied to
several biological problems such as prediction of pro-
tein-protein interactions [1-6], homology detection [12],
and analysis of gene expression data [13]. Data examples
labelled positive or negative are projected into a high-
dimensional feature space using a kernel, and the hyper-
plane in the feature space is optimized to maximize the
margin between positive and negative data examples.
We implemented an SVM model using LIBSVM http://
www.csie.ntu.edu.tw/~cjlin/libsvm/ with the radial basis
function (RBF) as a kernel function, which is defined by
K(u,v) = exp(−γ||u − v||2) (3)
where u and v are two data vectors and g is a training
parameter. A smaller g value makes the decision bound-
ary smoother. The regularization factor C controls
trade-off between a low training error and a large mar-
gin [14]. In this study, we set C = 20 and g=0.1.
We tried several other kernel functions with our data.
The linear and polynomial kernel functions resulted in
high sensitivity (almost 100%), but low specificity (about
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mance both in sensitivity and specificity (about 50%).
The radial basis function was the only one that showed
reasonably good sensitivity and specificity, and chosen
as the kernel function of the SVM model.
Data set of viral interaction with human proteins
Hepatitis C virus (HCV) is a small enveloped virus with a
single-stranded RNA genome encoding a single open
reading frame [15]. The polyprotein of approximately
3,100 amino acids is cleaved into the structural proteins
(core, E1 and E2), hydrophobic peptide p7, and non-
structural proteins such as NS2, NS3, NS4A, NS4B, NS5A
and NS5B [16]. Although many experimental studies have
been performed so far, the underlying mechanisms con-
trolling the entry of HCV into host cells and interactions
with the host cells are not fully known, and an efficient
treatment for HCV infection has not yet been developed.
We obtained the interaction data between HCV pro-
teins and human proteins from the infection mapping
project (I-MAP) [17]. I-MAP provides a comprehensive
view of viral infections at the protein level by mapping
the interactions of a large amount of viral proteins with
host proteins. There are 481 interactions between 11
HCV proteins and 421 human proteins. By searching
Gene IDs of the 421 human proteins in HPRD http://
www.hprd.org, we identified a total of 695 interactions
between HCV proteins and human proteins. The 695
protein-protein interactions formed a positive data set
for an SVM model. Both positive and negative data are
required to train an SVM model. Unlike positive data,
negative samples are not readily available from protein-
protein interaction data. We randomly selected 695
human proteins from HPRD, which were not included
in the positive data set, and generate a negative data set
with them. Our method of generating a negative data
set is similar to that of Gomez et al.[ 1 0 ] ,w h i c h
assumes a negative protein interaction if there is no
explicit evidence of an interaction. Since an unbalance
between positive and negative data sets introduces a
prediction bias, we generated a negative data set with
the same number of proteins as the positive data set.
For evaluating an SVM model, we divided both the
positive and negative data sets into training and test
sets. We randomly selected 500 positive data and 500
negative data for a training set. The remaining 195 posi-
tive data and 195 negative data were used to construct a
test set. To keep the same proportion of human proteins
interacting with each virus protein in both training and
test sets, we selected training data by
Ni = N(Training) ·
N(Ti)
N(Total)
(4)
where Ti is the i-th virus protein (i= 1 ,2 ,. . . ,1 1i n
HCV), N(Ti) is the number of human proteins interact-
ing with the i-th HCV protein, N(Training) is the total
number of positive training data, and N(Total) is the
total number of HCV-human protein interactions.
Table 1 shows the numbers of human proteins known
to interact with each HCV protein, and those selected
for a training set. For example, 298 human proteins are
known to interact with the HCV NS3 protein. 214 out
of the 298 human proteins were randomly selected as
positive data of a training set since N(NS3) = 500 × 298
/ 695 = 214. We selected the same number of human
proteins from a negative dataset as negative interaction
partners of the HCV NS3 protein.
Human papillomavirus (HPV) is a member of the
papillomavirus family of viruses that is capable of infect-
ing humans. HPV types 16 and 18 cause 70% of cervical
cancer [18,19]. So far, a small number of host proteins
have been known to interact with HPV proteins, so a sys-
tematic prediction of large-scale interactions between
HPV proteins and human proteins would help find new
human proteins targeted by HPV. We extracted the
interactions of HPV-16 and HPV-18 proteins with
human proteins from the NCBI BioSystems Database
(http://www.ncbi.nlm.nih.gov/biosystems/). After remov-
ing redundancy, we identified a total of 252 interactions
of HPV proteins with human proteins, and obtained
Gene IDs from HPRD http://www.hprd.org. A training
set and test set for HPV interactions were constructed in
the same way as for the HCV interactions. Table 2 shows
the numbers of human proteins known to interact with
Table 1 The number of human proteins interacting with
HCV proteins
HCV protein Number of HHCV Number of HHCV in a training set
core 118 85
E1 16 12
E2 29 21
F1 0 7
NS2 11 8
NS3 298 214
NS4A 7 5
NS4B 1 1
NS5A 152 109
NS5B 36 26
p7 17 12
Total 695 500
HHCV represents the human proteins that are known to interact with HCV
proteins. For each HCV protein, the number of HHCV in a training set was
computed by Ni = N(Training) ·
N(Ti)
N(Total)
, where Ti is the i-th HCV
protein.
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for HPV interactions.
Results and discussion
Performance evaluation
We evaluated the performance of the SVM model in
terms of sensitivity, specificity and accuracy.
Sensitivity =
TP
TP + FN
(5)
Speciﬁcity =
TN
TN + FP
(6)
Accuracy =
TP + TN
TP + FP + TN + FN
(7)
True positives (TP) are actual interacting proteins that
are predicted correctly. True negatives (TN) are non-
interacting proteins that are predicted correctly. False
positives (FP) are non-interacting proteins that are pre-
dicted as interacting proteins. False negatives (FN) are
interacting proteins that are missed.
We did not perform cross validation to evaluate the
SVM model. Instead, we prepared independent test sets
that were not used in training the SVM model. In gen-
eral, cross-validation shows a much higher performance
than testing a prediction model on a new data set that
was not used in training. As shown later in this paper,
some virus proteins have a very small number of human
protein interaction partners to perform cross validation.
For example, the HCV NS4A and HCV NS4B proteins
have only 7 and 1 interaction partners, respectively. The
HPV E4 protein has only 2 interaction partners, and the
HPV E8 protein has only 7 interaction partners. Thus,
we tested the SVM model on new, independent data
sets that were not used in training the model.
Interaction of HCV proteins
Due to the randomness in drawing negative data from
H P R Da n dp o s i t i v ed a t af r o mt h ed a t as e to fH C V -
human protein interactions for the training set, we pre-
pared three independent test sets and evaluated the SVM
model with the sets (Additional file 1). For comparison,
we also tested the method of Shen et al. [5] on these sets.
Table 3 compares our method with Shen’sm e t h o di n
terms of sensitivity, specificity and accuracy with the
HCV data.
As shown in Table 3, our SVM model, on average,
achieved a sensitivity of 77.8%, a specificity of 85.4% and
an accuracy of 81.6%. It outperformed the method of
Shen et al. [5], which on average, achieved a sensitivity of
74.0%, a specificity of 80.4% and an accuracy of 77.1%. In
particular, our method showed the best performance in
the second test set.
To find new human proteins that potentially interact
w i t hH C Vp r o t e i n s( H HCV), we ran BLAST http://www.
ncbi.nlm.nih.gov/BLAST/ with the known HHCV as query
sequences against the human proteins in GenBank
http://www.ncbi.nlm.nih.gov/genbank/. The E-value was
set to 10
-20 when running BLAST. After removing redun-
dant sequences with the 695 known HHCV proteins, we
obtained a total of 4,209 human proteins as the initial
candidates of HHCV (Table 4).
In the 4,209 human proteins, the SVM model predicted
1,180 proteins as potential candidates of HHCV. The 1,180
candidates of HHCV were refined further by selecting
human proteins that have the same gene ontology (GO)
cellular component terms [20] as the known HHCV for
each HCV protein. After this refinement, we obtained a
total of 456 candidates of HHCV. For instance, the HCV E2
protein has 29 known HHCV proteins, and the 29 HHCV
proteins have a total of 15 GO cellular component terms.
The SVM model predicted 33 HHCV proteins as interact-
ing partners of the HCV E2 protein, and 10 out of the 33
Table 2 The number of human proteins interacting with
HPV proteins
HPV protein Number of HHPV Number of HHPV in a training set
E1 9 7
E2 36 29
E4 2 2
E5 13 10
E6 78 62
E7 76 60
E8 7 6
L1 20 16
L2 11 8
Total 252 200
HHPV represents the human proteins that are known to interact with HPV
proteins. For each HPV protein, the number of HHPV in a training set was
computed by Ni = N(Training) ·
N(Ti)
N(Total)
, where Ti is the i-th HPV
protein.
Table 3 Comparison of two representation methods for
predicting human proteins interacting with HCV proteins
Test set Our representation Shen’s representation
SN (%) SP (%) AC (%) SN (%) SP (%) AC (%)
1 75.9 83.6 79.7 73.8 82.1 77.9
2 80.5 89.7 85.1 73.8 82.1 77.9
3 76.9 83.1 80 74.4 76.9 75.6
Average 77.8 85.4 81.6 74.0 80.4 77.1
Comparison of our representation method with the method by Shen et al.[ 5 ]
in terms of sensitivity (SN), specificity (SP) and accuracy (AC) with the HCV
data. The two representation methods are different in their classification of 20
amino acids and definition of the relative frequency of an amino acid triplet
(see Methods section for details).
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they have the same GO cellular component terms as the
known HHCV proteins. Figure 1 shows an interaction net-
work of the 456 HHCV proteins predicted by our method.
Interaction of HPV proteins
To evaluate the performance of the model with the HPV
datasets, we prepared three training sets and three test sets
(Additional file 2). We tested both our method and Shen’s
Table 4 New human proteins found by our method as potential interaction partners with HCV proteins
HCV
protein
Known
HHCV
Initial candidates of HHCV by BLAST
search
Predicted candidates of HHCV by
SVM
Refined candidates of HHCV with
GO
core 118 732 225 71
E1 16 150 28 9
E2 29 182 33 10
F 10 206 57 12
NS2 11 176 42 8
NS3 298 1,599 495 195
NS4A 7 114 33 10
NS4B 1 1 1 1
NS5A 152 499 123 72
NS5B 36 384 92 51
p7 17 166 51 17
Total 695 4,209 1,180 456
The ‘Initial candidates of HHCV by BLAST search’ indicate the initial candidates of human proteins interacting with HCV proteins (called HHCV in this paper) found
by BLAST search from GenBank with the known HHCV as query sequences. The ‘Predicted candidates of HHCV by SVM’ were determined by the SVM model from
the initial candidates of HHCV. The ‘Refined candidates of HHCV with GO’ were obtained from the predicted candidates by selecting HHCV that have the same GO
cellular component terms as the known HHCV.
Figure 1 A network of the human-HCV protein interactions predicted by our method. The network visualized by Cytoscape [21] includes
11 HCV proteins (core, E1, E2, F, NS2, NS3, NS4A, NS4B, NS4A, NS5B, and p7) and 456 human proteins. The HCV proteins are represented by
yellow nodes, and human proteins are shown by nodes with HPRD IDs.
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method achieved on average, a sensitivity of 78.8%, a speci-
ficity of 87.8% and an accuracy of 83.3%. Shen’sm e t h o d
showed, on average, a sensitivity of 72.4%, a specificity of
83.9% and an accuracy of 78.2%. In both HCV and HPV
data sets, our method was better than Shen’s method. The
major difference between our method and Shen’s method
is in the representation of protein sequences. Our classifi-
cation of 20 amino and definition of the relative frequency
of an amino acid triplet are different from those of Shen’s
method (see the Methods section for details).
To find new human proteins that potentially interact
with HPV proteins (HHPV), we ran BLASTP http://www.
ncbi.nlm.nih.gov/BLAST/ with the E-value ≤ 10
-20
against the human proteins in GenBank http://www.ncbi.
nlm.nih.gov/genbank/. After removing redundant
sequences with the 252 known HHPV proteins, we
obtained a total of 560 human proteins as the initial can-
didates of HHPV (Table 6). In the 560 HHPV proteins, the
SVM model predicted 156 proteins as potential candi-
dates of HHPV. In the 156 HHCV proteins, we selected the
human proteins that have the same cellular component
G OI D sa st h ek n o w nH HPV for each HPV protein. As a
result, we found a total of 130 human proteins as poten-
tial HHPV. Figure 2 shows an interaction network of 130
HHPV proteins that were predicted by our method.
Comparative analysis of two viral interaction networks
In viral infections, different viruses target different
human proteins, so they usually have interaction part-
ners. We compared the interaction network of HCV with
that of HPV to find common human protein targets. Fig-
ure 3A shows the HCV interaction network overlaid by
the HPV interaction network, both for the known inter-
action data. HCV and HPV have 11 human proteins as
their common interaction partners: STAT3 (HPRD
00026), CDKN1A (HPRD 00298), NR4A1 (HPRD 00744),
JUN (HPRD 01302), TP53 (HPRD 01859), TP73 (HPRD
03587), IPO5 (HPRD 03597), FADD (HPRD 03909),
FHL2 (HPRD 04026), EP300 (HPRD 04078), and
AHNAK (HPRD 14684). In particular, four human pro-
teins, CDKN1A (HPRD 00298), TP53 (HPRD 01859),
TP73 (HPRD 03587), and FADD (HPRD 03909) proteins,
shown in Figure 3B, are the common interaction partners
of the HCV core protein and HPV E6 protein. They are
k n o w nt ob ee n g a g e di nt h ep 5 3s i g n a l l i n gp a t h w a yf o r
apoptosis http://www.sabiosciences.com/rt_pcr_product/
HTML/PAHS-027A.html.
In a similar way, we compared the predicted interaction
n e t w o r ko fH C Va n dt h a to fH P V( F i g u r e4 ) .H C Va n d
HPV have 7 human proteins as their common interaction
partners (pink nodes in the network): SLC1A1 (HPRD
00597), KRT17 (HPRD 01019), TP63 (HPRD 04469),
GSK3B (HPRD 05418), CDK19 (HPRD 07627), CDK11B
(HPRD 08909), and NLK (HPRD 17637).
Conclusions
Most methods for predicting protein-protein interac-
tions focus on the interactions within a species rather
than for the interactions across different species, such as
interactions between virus and host cell proteins. In this
paper we presented a support vector machine (SVM)
model and its representation method for predicting the
interactions between viruses and human proteins.
We represented a protein sequence using three conse-
cutive amino acids called amino acid triplet. We
mapped a protein sequence of variable length to a fea-
ture vector of fixed length, and then mapped the feature
vector to a frequency vector that represents the relative
frequency of each triplet within the protein sequence.
The SVM model showed an average accuracy of 81.6%
in predicting human proteins that interact with HCV
proteins, and a similar accuracy (83.3%) in predicting
human proteins that interact with HPV proteins. The
performance of our SVM model was better than that of
the other method [5] in both data sets of HCV and
HPV. Using the SVM model and Gene Ontology (GO)
annotations of proteins, we also predicted new human
proteins that potentially interact with HCV or HPV pro-
teins. From the comparative analysis of two viral inter-
action networks, we found common human proteins
that are targeted by both viruses.
Our experiment on 2 different types of viruses showed
that encoding the relative frequency of amino acid tri-
plets of a protein sequence is a simple yet powerful
representation method for protein sequences when
Table 5 Comparison of two methods for predicting human proteins interacting with HPV proteins
Test set Our representation Shen’s representation
SN (%) SP (%) AC (%) SN (%) SP (%) AC (%)
1 86.5 88.5 87.5 69.2 84.6 76.9
2 73.1 88.5 80.8 69.2 84.6 76.9
3 76.9 86.5 81.7 78.8 82.7 80.8
Average 78.8 87.8 83.3 72.4 83.9 78.2
Comparison of our representation method with the method by Shen et al. [5] in terms of sensitivity (SN), specificity (SP) and accuracy (AC) with the HPV data.
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cies. The representation method has several advantages.
First, it enables a prediction model to achieve better
performance than that of other representations. Second,
it generates feature vectors of fixed length regardless of
the sequence length. Third, the same representation is
applicable to different types of proteins.
Elucidating virus-host interactions is important for
understanding viral infections and for identifying new
targets for rational drug discovery. In the future, we
plan to construct virus-host protein interaction net-
works to achieve more viral species and perform further
comparative analysis of the interaction networks to dis-
cover interaction patterns central or specific to them.
Table 6 New human proteins found by our method as potential interaction partners with HPV proteins
HPV
protein
Known
HHPV
Initial candidates of HHPV by BLAST
search
Predicted candidates of HHPV by
SVM
Refined candidates of HHPV with
GO
E1 9 90 7 6
E2 36 157 28 21
E4 2 11 2 2
E5 13 34 25 23
E6 78 103 38 29
E7 76 100 35 29
E8 7 19 8 8
L1 20 39 8 7
L2 11 7 5 5
Total 252 560 156 130
The ‘Initial candidates of HHPV by BLAST search’ indicate the initial candidates of human proteins interacting with HPV proteins (HHPV) found by BLAST search
from GenBank with the known HHCV as query sequences. The ‘Predicted candidates of HHPV by SVM’ were determined by the SVM model from the initial
candidates of HHPV. The ‘Refined candidates of HHPV with GO’ were obtained from the predicted candidates by selecting HHCV that has the same GO cellular
component terms as the known HHPV.
Figure 2 A network of the human-HPV protein interactions predicted by our method. The network includes 9 HPV proteins (E1, E2, E4, E5,
E6, E7, E8, L1, L2) and 130 human proteins. The HPV proteins and human proteins are represented by yellow nodes and HPRD IDs, respectively.
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Page 7 of 10Figure 3 Comparison of the HCV interaction network with the HPV interaction network for the known interactions.( A )T h eH C V
interaction network is overlaid by the HPV interaction network by WebInterViewer [22]. Both networks show the known interactions of HCV and
HPV with human proteins. HCV and HPV have 11 human proteins as their common interaction partners: STAT3 (HPRD 00026), CDKN1A (HPRD
00298), NR4A1 (HPRD 00744), JUN (HPRD 01302), TP53 (HPRD 01859), TP73 (HPRD 03587), IPO5 (HPRD 03597), FADD (HPRD 03909), FHL2 (HPRD
04026), EP300 (HPRD 04078), and AHNAK (HPRD 14684). Pink node: human protein interacting with both HCV and HPV proteins; yellow node:
HCV protein, cyan node: HPV protein; white node: human protein interacting with either HCV protein or HPV protein but not both. (B) The
CDKN1A (HPRD 00298), TP53 (HPRD 01859), TP73 (HPRD 03587), and FADD (HPRD 03909) proteins in the red box are the common interaction
partners of the HCV core protein and HPV E6 protein. They are known to be engaged in the p53 signaling pathway for apoptosis http://www.
sabiosciences.com/rt_pcr_product/HTML/PAHS-027A.html.
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Page 8 of 10Additional material
Additional file 1: Three data sets used for predicting human
proteins interacting with HCV proteins. Three training and test sets of
human proteins (HPRD IDs) that were used for the results of Table 3.
Additional file 2: Three data sets used for predicting human
proteins interacting with HPV proteins. Three training and test sets of
human proteins (HPRD IDs) that were used for the results of Table 5.
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